Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models.

Front Oncol · 2022 · PMC9668006 · PMID 36408162

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

The effect of ABTL0812 on all these parameters shows a clear trend towards a greater modification than with everolimus in both U87MG ( Figure 6C ) and T98G cells ( Figure 6D ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.